Stelliam Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,702,500
| Closed | -$91.1M | – | 44 |
|
|
2016
Q1 | $91.1M | Buy |
1,702,500
+437,500
| +35% | +$23.4M | 2.82% | 15 |
|
|
2015
Q4 | $83M | Sell |
1,265,000
-380,000
| -23% | -$24.9M | 2.48% | 15 |
|
|
2015
Q3 | $92.9M | Buy |
1,645,000
+285,000
| +21% | +$16.1M | 2.31% | 12 |
|
|
2015
Q2 | $80.4M | Buy |
1,360,000
+270,000
| +25% | +$16M | 1.7% | 18 |
|
|
2015
Q1 | $67.9M | Sell |
1,090,000
-165,000
| -13% | -$10.3M | 1.53% | 26 |
|
|
2014
Q4 | $72.2M | Buy |
1,255,000
+337,500
| +37% | +$19.4M | 1.66% | 19 |
|
|
2014
Q3 | $49.3M | Buy |
+917,500
| New | +$49.3M | 1.3% | 37 |
|
|
2013
Q4 | – | Sell |
-1,837,500
| Closed | -$69.4M | – | 56 |
|
|
2013
Q3 | $69.4M | Buy |
1,837,500
+455,000
| +33% | +$17.2M | 3.31% | 4 |
|
|
2013
Q2 | $54.2M | Buy |
+1,382,500
| New | +$54.2M | 2.94% | 9 |
|